E. Beckmann et al.
FULL PAPER
dropwise at Ϫ40 °C, over 60 minutes, to a solution of 31a (1.00 g,
lated; m.p.176Ϫ177 °C. IR (KBr): ν˜ ϭ 1621 cmϪ1, 1489 (CϭC).
6.8 mmol) in anhydrous THF (25 mL). After having been slowly 1H NMR: δ ϭ 7.45Ϫ7.2 (m, 10 H), 4.55 (d, CH2), 3.95 (d, CH2),
warmed up (12 h) and then heated at reflux (2 h), the mixture was
hydrolyzed (satd. aqueous NH4Cl, pH 7). After the bulk of the
THF had been distilled, the residue was extracted with CH2Cl2 (5
ϫ 30 mL). After standard workup, the colorless solid was purified
by flash chromatography (silica gel, CH2Cl2/cyclohexane, 1:1, Rf
(32) ϭ 0.11) and crystallized (CH2Cl2/cyclohexane, 1:1). 1.00 g
(82%) of colorless crystals were isolated; m.p. 151 °C. IR (KBr):
3.02 (10-,12-H), 3.00 (d, 5-,13-Hs), 2.01 (ddd, 5-,13-Ha), 1.90 (t, 11-
H), 1.48 (s, 2 CH3) ppm; J5,5Ј(13,13Ј) ϭ 14.0, J10,11(11,12) ϭ 3.1 Hz.
13C NMR (400 MHz): δ ϭ 159.4 (C-1,-6), 140.2, 128.4, 128.3,
126.8, 80.7 (C-4,-9), 52.3 (2 CH2), 51.6 (C-10,-12), 30.7 (C-5,-13),
24.1 (CH3), 17.6 (C-11) ppm. MS: m/z (%) ϭ 384 (15) [M·ϩ], 293
[M Ϫ C6H5CH2]ϩ, 199 (88), 91 (100). C25H28N4 (384.5): calcd. C
78.09, H 7.34, N 14.57, found C 77.61, H 7.15, N 14.13.
1
ν˜ ϭ 3350 cmϪ1 (OH), 1640 (CϭC). H NMR: δ ϭ 5.82 (dd, 2-,6-
4,9-Dimethyl-3,8-bis(phenylsulfonyl)-2,3,7,8-tetraazatetracyclo-
[7.3.1.04,12.06,10]trideca-1,6-diene (33e): See 3e. A solution of freshly
prepared 33b (590 mg, 3.0 mmol) and benzenesulfonyl chloride
(1.5 mL, 11.8 mmol) in pyridine (5 mL) was stirred, under ex-
clusion of air, at room temp. for 12 h. After standard workup and
crystallization (methanol), colorless crystals (1.05 g, 72%) were ob-
tained; m.p. 222 °C Rf(CHCl3/MeOH, 10:1) ϭ 0.38. IR (KBr): ν˜ ϭ
H), 5.60 (d, 3-,7-H), 2.31 (dt, l-,5-H), 1.91 (t, 2 H, 9-H), 1.64 (s,
OH), 1.36 (s, 2 CH3) ppm; J1,2(5,6) ϭ 6.0, J1,9 ϭ 3.1, J2,3(6,7)
ϭ
9.8 Hz. 13C NMR: δ ϭ 135.8 (C-2,-6), 128.3 (C-3,-7), 74.3 (C-4,-
8), 40.4 (C-1,-5), 29.5 (C-9), 27.7 (CH3) ppm. CI MS (isobutane):
m/z (%) ϭ 163 (10) [M ϩ H Ϫ H2O]ϩ, 145 (100) [M ϩ H Ϫ
2H2O]ϩ. C11H16O2 (180.3): calcd. C 73.27, H 8.96; found C 73.89,
H 9.01. An occasional by-product was identified as separately pre-
pared 36.
1
1622 cmϪ1, 1471, 1446, 1339. H NMR: δ ϭ 8.02Ϫ7.98 (m, 4 H),
7.59Ϫ7.49 (m, 6 H), 3.05 (d, 5-,13-Hs), 2.92 (t, 10-,12-H), 2.21 (d,
5-,13-Ha), 1.89 (t, 11-H), 1.88 (s, 2 CH3) ppm; J5,5Ј(13,13Ј) ϭ 14.3,
J10,11(11,12) ϭ 2.7 Hz. 13C NMR(400 MHz): δ ϭ 163.9 (C-1,-6),
2,3,7,8-Tetraazatetracyclo[7.3.1.04,12.06,10]trideca-1,6-diene (33a):
See 3b. A solution of 31a (148 mg, 1.0 mmol) in ethanol (30 mL)
was added dropwise over 3 h to a solution of hydrazine hydrate 140.7 (C-15,-13), 24.2 (2 CH3), 15.2 (C-11) ppm. FAB-MS: m/z
(100 mg, 2.0 mmol) in ethanol (2 mL). This system was stirred for
12 h and heated at reflux until total conversion (3 h, TLC). After
concentration in vacuo the solid residue was practically pure, air-
sensitive 33a [175 mg, 100%, Rf(CHCl3/CH3OH, 12:1) ϭ 0.11]
(%) ϭ 485 (66) [M·ϩ], 343 (40 [M Ϫ PHsO2]ϩ, 307 (40), 154 (100),
136 (80). C23H24N4O4S2 (484.6).
2,3,7,8-Tetraazatetracyclo[7.3.1.04,12.06,10]trideca-2,7-diene (34a):
See 4b. Hydrazine hydrate (850 mg, 17.0 mmol)/ethanol (5 mL)/31a
(1.00 g, 6.8 mmol)/ethanol (100 mL), room temperature. After
complete formation of 33a (TLC) and addition of K2CO3 (2.35 g,
17.0 mmol), the mixture was heated at reflux until total conversion
(TLC, 5Ϫ7 h). After standard workup (CH2Cl2), chromatography
(silica gel, CH2Cl2/acetone, 10:1), and concentration of the major
fraction, the residue was crystallized from CH3CN to afford color-
less prisms (720 mg, 60%) ; m.p. 175 °C (dec., N2 elimination). UV
(CH3CN): λmax (ε) ϭ 333 nm (790), 201 (845). IR (KBr): ν˜ ϭ 1550
1
which was used as such. H NMR (CD3OD): δ ϭ 4.14 (t, 4-,9-H),
3.25 (m, 10-,12-H), 2.61 (ddd, 5-,13-Hs), 2.34 (d, 5-,13-Ha),2.21 (t,
11-H) ppm; J4,5(9,13) ϭ 5.7, J4,12(9,10) ϭ 6.0, J5,5Ј ϭ 13.5, J5,12(10,13) ϭ
1.5, J10,11(11,12) ϭ 3.0 Hz. 13C NMR(CD3OD): δ ϭ 163.6 (C-1,-6),
69.1 (C-4, Ϫ9), 46.1 (C-10,-12), 32.7 (C-5,-13), 17.9 (C-11) ppm.
HRMS: calcd. for C9H12N4 176.1062; found 176.1054.
4,9-Dimethyl-2,3,7,8-tetraazatetracyclo[7.3.1.04,12.06,10]trideca-1,6-
diene (33b): See 33a. Hydrazine hydrate (355 mg, 7.1 mmol)/ethanol
(10 mL)/31b (500 mg, 2.84 mmol)/ethanol (150 mL)/3(12) h. After cmϪ1 (NϭN). 1H NMR: δ ϭ 4.92 (ddd,1-,4-,6-,9-H), 3.07 (dt,
concentration in vacuo, the solid residue was practically pure, air-
5-,13-Hs), 2.35 (tt, 10-,12-H), 1.88 (dt, 5-,13-Ha), 1.57 (t, 11-H)
1
sensitive 33b (590 mg, 100%) and was used as such. H NMR: δ ϭ ppm; J1(4),12:6(9),10) ϭ 10.5, J1,13Ј(13Ј,9;6,5Ј;5Ј,4) ϭ 1.5, J1,13(13,9;6,5;5,4) ϭ
5.35 (br., 2 NH), 2.89 (t, 10-,12-H), 2.45 (d, 5-,13-Hs), 2.33 (d, 6.9,, J5,5Ј(13,13Ј) ϭ 16.2, J10,11 ϭ 3.0 Hz. 13C NMR: δ ϭ 85.2
5-,13-Ha), 1.92 (t, 11-H), 1.48 (s, 2 CH3) ppm; J10,11(11,12) ϭ 3.1,
J5,5Ј(12,12Ј) ϭ 13.4 Hz.
(C-1,-4,-6,-9), 23.7 (C-10,-12), 18.5 (C-5,-13), 15.6 (C-11) ppm. MS:
m/z ϭ 176 (14) [M·ϩ], 79 (100). C9H12N4 (176.3): calcd. C 61.31,
H 6.87, N 31.79; found C 60.98, H 6.71, N 31.91.
3,8-Dibenzyl-2,3,7,8-tetraazatetracyclo[7.3.1.04,12.06,10]trideca-1,6-
diene (33c): A solution of freshly prepared 33a (600 mg, 3.4 mmol)
and benzyl bromide (1.71 g, 10 mmol) was heated at 80 °C for 16
1,6-Dimethyl-2,3,7,8-tetraazatetracyclo[7.3.1.04,12.06,10]trideca-2,7-
diene (34b): See 34a. Hydrazine hydrate (794 mg, 14.2 mmol/etha-
h in the presence of K2CO3 (500 mg). After standard workup and nol (5 mL)/31b (1.00 g, 5.7 mmol)/ethanol (100 mL)/K2CO3
flash chromatography (silica gel, ethyl acetate/cyclohexane, 2:1), the
major fraction (Rf ϭ 0.34) was concentrated in vacuo and the yel-
lowish residue was crystallized (diethyl ether) to afford colorless
crystals (850 mg, 70%); m.p.125 °C. IR (KBr): ν˜ ϭ 1609 cmϪ1 (Cϭ
(1.97 g, 14.2 mmol)/reflux, 5Ϫ7 h. Colorless needles (930 mg, 80%)
were recovered; m.p. 158 °C (CH3CN) (dec., N2 elimination),
Rf(CH2Cl2/ethyl acetate, 1:1) ϭ 0.27. IR (KBr): ν˜ ϭ 1563 cmϪ1
(NϭN). UV (CH3CN): λmax (ε) ϭ 334 nm (408), 196 (970). 1H
N), 1488 (CϭC). 1H NMR: δ ϭ 7.50Ϫ7.11 (m, 10 H), 4.68 (d, NMR: δ ϭ 4.97 (ddd, 4-,9-H), 2.89 (dd, 5-,13-Hs), 1.70 (dt, 10-,12-
CH2), 4.24 (d, CH2), 4.07 (t, 4-,9-H), 3.28 (m, 10-,12-H), 3.0 (d, H), 1.56 (dd, 5-,13-Ha), 1.50 (t, 11-H), 1.36 (s, 2 CH3) ppm;
5-, 13-Hs), 2.02 (ddd, 5-,13-Ha), 2.00 (t, 11-H) ppm; J4,5(9,13)
J4,12(9,10) ϭ 6.0, J5,5Ј(13,13Ј) ϭ 14.2, J5,12(10,13) ϭ 1.4, J10,11(11,12)
ϭ
J4,12(9,10) ϭ 10.5, J4,5Ј(9,13Ј) ϭ 1.5, J4,5(9,13) ϭ 7.4, J10,11(11,12) ϭ 3.1,
J5,5Ј(13,13Ј) ϭ 15.8 Hz. 13C NMR: δ ϭ 89.8 (C-1,-6), 87.0 (C-4,-9),
31.1 (C-10,-12), 28.0 (CH3), 26.1 (C-5,-13), 16.9 (C-11) ppm.
ϭ
3.0 Hz. 13C NMR (400 MHz): δ ϭ 160.2 (C-1,-6), 138.7, 128.7,
128.5, 127.1 (12 C), 71.9 (C-4,-9), 53.8 (2 CH2), 45.7 (C-10,-12), C11H16N4 (204.3): calcd. 64.68 H 7.89 N 27.43; found C 64.49, H
24.2 (C-5,-13), 18.1 (C-11) ppm. MS: m/z (%) ϭ 356 (18) [Mϩ], 91 7.99, N 27.12.
(100). HRMS: calcd. for C23H24N4 356.2000; found 356.2010.
1,4,6,9-Tetramethyl-2,3,7,8-tetraazatetracyclo[7.3.1.04,12.06,10]-
3,8-Dibenzyl-4,9-dimethyl-2,3,7,8-tetraazatetracyclo- trideca-2,7-diene (34c): See 4d. A solution of 33e (1.82 g, 3.8 mmol)
[7.3.1.04,12.06,10]trideca-1,6-diene (33d): See 33c. Freshly prepared
33b (ca. 600 mg, 2.8 mmol), benzyl bromide (1.7 g, 10 mmol)/
K2CO3 (500 mg)/80 °C/16 h. After standard workup, flash chroma-
tography (silica gel, ethyl acetate/cyclohexane, 2:1, Rf ϭ 0.15), and
crystallization (THF), colorless crystals (650 mg, ca. 60%) were iso-
in THF (150 mL) was slowly added (2 h) at room temperature to
a stirred suspension of the MeLi/CeCl3 reagent prepared at Ϫ78
°C in THF (CeCl3, 2.60 g, 10.6 mmol, THF, 150 mL, MeLi,
6.4 mL, 1.6 diethyl ether, 10.3 mmol). Stirring was continued for
10 h. After hydrolysis (aqueous NH4Cl), standard workup (diethyl
4260
2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2003, 4248Ϫ4264